GUTS Fractyl Health, Inc.
Fundamentals / CIK 0001572616 / USDFractyl Health, Inc. reported $0 in revenue and a net loss of $74.20M for the fiscal year ended December 31, 2025 (down 100.0% year over year).
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open GUTS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$0 -100.0% YoY
-
Operating Income FY 2025-$81.85M Operating profit
-
Net Income FY 2025-$74.20M GAAP bottom line
-
Diluted EPS FY 2025-$5.60 Split-adjusted
-
Free Cash Flow FY 2025-$90.89M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$31.52M Total debt: $29.89M
Annual revenue and net income
3 fiscal years (2023 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Revenue | $0 | $93K | $120K |
| Cost of Revenue | $0 | $50K | $77K |
| Gross Profit | $0 | $43K | $43K |
| Research & Development | $74.54M | $70.47M | $38.04M |
| Selling, General & Admin | $22.28M | $23.10M | $12.84M |
| Total Operating Expenses | $96.82M | $93.57M | $50.88M |
| Operating Income | -$96.82M | -$93.53M | -$50.84M |
| EBITDA | -$95.69M | -$92.85M | -$50.55M |
| Interest Income | $1.54M | $4.15M | $1.26M |
| Income Tax Expense | $0 | $0 | $0 |
| Net Income | -$141.0M | -$68.69M | -$77.09M |
| Basic EPS | -$1.86 | -$1.62 | -$45.31 |
| Diluted EPS | -$1.86 | -$1.62 | -$45.31 |
| Basic Shares Outstanding | 75.8M | 43.5M | 2.1M |
| Diluted Shares Outstanding | 75.8M | 43.5M | 2.1M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- | -- | $3.0K |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | -- | $0 |
| Gross Profit | -- | -- | -- | -- | -- | -- | -- | $3.0K |
| Research & Development | $12.45M | $13.81M | $15.60M | $16.49M | $17.46M | $21.15M | $19.43M | $20.28M |
| Selling, General & Admin | $6.20M | $5.28M | $5.22M | $6.79M | $5.24M | $4.93M | $5.32M | $4.93M |
| Total Operating Expenses | $18.65M | $19.10M | $20.82M | $23.28M | $22.69M | $26.08M | $24.76M | $25.21M |
| Operating Income | -$18.65M | -$19.10M | -$20.82M | -$23.28M | -$22.69M | -$26.08M | -$24.76M | -$25.21M |
| EBITDA | -$18.37M | -$18.82M | -$20.54M | -$23.00M | -$22.40M | -$25.81M | -$24.47M | -$24.99M |
| Interest Income | $297K | $431K | $593K | $645K | $166K | $226K | $503K | $726K |
| Net Income | -$14.15M | -$25.54M | $9.22M | -$43.73M | -$45.60M | -$27.89M | -$23.73M | -$24.97M |
| Basic EPS | -$1.07 | -$0.16 | $0.06 | -- | -$8.46 | -$0.57 | -$0.49 | -- |
| Diluted EPS | -$1.07 | -$0.16 | $0.06 | -- | -$8.46 | -$0.57 | -$0.49 | -- |
| Basic Shares Outstanding | 13.3M | 158.6M | 158.4M | -- | 5.4M | 49.0M | 48.8M | -- |
| Diluted Shares Outstanding | 13.3M | 158.6M | 158.4M | -- | 5.4M | 49.0M | 48.8M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Cash & Cash Equivalents | $81.54M | $67.46M | $33.21M |
| Cash & Short-Term Investments | $81.54M | $67.46M | $33.21M |
| Accounts Receivable, Net | -- | $0 | $22K |
| Inventory | -- | $73K | $73K |
| Total Current Assets | $87.58M | $71.76M | $35.65M |
| Property, Plant & Equipment, Net | $2.41M | $2.98M | $490K |
| Other Non-Current Assets | $337K | $666K | $5.54M |
| Total Non-Current Assets | $33.83M | $36.31M | $40.56M |
| Total Assets | $121.4M | $108.1M | $76.21M |
| Accounts Payable | $1.57M | $3.24M | $553K |
| Total Current Liabilities | $18.33M | $19.77M | $11.19M |
| Other Non-Current Liabilities | $663K | $998K | -- |
| Total Non-Current Liabilities | $93.61M | $59.88M | $102.8M |
| Total Liabilities | $111.9M | $79.65M | $113.9M |
| Total Debt (incl. Leases) | $31.06M | $32.34M | $31.24M |
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | -$556.3M | -$415.3M | -$346.6M |
| Total Stockholders' Equity | $9.46M | $28.42M | -$325.1M |
| Total Equity | $9.46M | $28.42M | -$325.1M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $31.52M | $47.14M | $63.17M | $81.54M | $77.66M | $22.29M | $42.11M | $67.46M |
| Cash & Short-Term Investments | $31.52M | $47.14M | $63.17M | $81.54M | $77.66M | $22.29M | $42.11M | $67.46M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | -- | $0 |
| Inventory | -- | -- | -- | -- | -- | -- | -- | $73K |
| Total Current Assets | $34.33M | $49.60M | $65.92M | $87.58M | $79.70M | $26.69M | $47.05M | $71.76M |
| Property, Plant & Equipment, Net | $1.69M | $1.85M | $2.13M | $2.41M | $2.68M | $2.96M | $3.14M | $2.98M |
| Other Non-Current Assets | $132K | $304K | $681K | $337K | $392K | $458K | $571K | $666K |
| Total Non-Current Assets | $31.59M | $32.37M | $33.47M | $33.83M | $34.57M | $35.32M | $35.99M | $36.31M |
| Total Assets | $65.92M | $81.98M | $99.39M | $121.4M | $114.3M | $62.01M | $83.04M | $108.1M |
| Accounts Payable | $1.73M | $1.01M | $1.65M | $1.57M | $1.26M | $3.91M | $1.48M | $3.24M |
| Total Current Liabilities | $17.34M | $15.74M | $15.41M | $18.33M | $18.68M | $21.83M | $18.80M | $19.77M |
| Other Non-Current Liabilities | $555K | $510K | $569K | $663K | $753K | $838K | $920K | $998K |
| Total Non-Current Liabilities | $61.80M | $67.91M | $62.60M | $93.61M | $98.77M | $58.39M | $57.86M | $59.88M |
| Total Liabilities | $79.14M | $83.64M | $78.01M | $111.9M | $117.5M | $80.22M | $76.67M | $79.65M |
| Total Debt (incl. Leases) | $29.89M | $30.29M | $30.68M | $31.06M | $31.41M | $31.73M | $32.04M | $32.34M |
| Common Stock | $0 | $1.0K | $1.0K | $0 | $1.0K | $0 | $0 | $0 |
| Retained Earnings | -$586.7M | -$572.6M | -$547.0M | -$556.3M | -$512.5M | -$466.9M | -$439.0M | -$415.3M |
| Total Stockholders' Equity | -$13.22M | -$1.67M | $21.38M | $9.46M | -$3.18M | -$18.21M | $6.38M | $28.42M |
| Total Equity | -$13.22M | -$1.67M | $21.38M | $9.46M | -$3.18M | -$18.21M | $6.38M | $28.42M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Net Income | -$141.0M | -$68.69M | -$77.09M |
| Depreciation & Amortization | $1.13M | $677K | $286K |
| Stock-Based Compensation | $6.68M | $14.43M | $4.30M |
| Change in Receivables | -- | $22K | -$22K |
| Change in Inventory | $73K | -- | -$73K |
| Change in Payables | -$1.67M | $2.69M | -$427K |
| Operating Cash Flow | -$90.33M | -$65.52M | -$42.82M |
| Capital Expenditure | -$557K | -$1.76M | -$359K |
| Free Cash Flow | -$90.89M | -$67.29M | -$43.18M |
| Investing Cash Flow | -$557K | -$1.76M | -$359K |
| Common Stock Issued | $6.78M | -- | -- |
| Financing Cash Flow | $105.0M | $101.2M | $27.44M |
| Net Change in Cash | $14.08M | $33.94M | -$15.74M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$14.15M | -$25.54M | $9.22M | -$43.73M | -$45.60M | -$27.89M | -$23.73M | -$24.97M |
| Depreciation & Amortization | $276K | $278K | $281K | $279K | $290K | $270K | $290K | $223K |
| Stock-Based Compensation | $2.39M | $2.50M | $2.53M | $1.85M | $1.64M | $1.78M | $1.41M | $2.90M |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -- | $0 |
| Change in Inventory | -- | -- | -- | $0 | $0 | $0 | $73K | -- |
| Change in Payables | $704K | -$643K | $75K | $318K | -$2.65M | $2.43M | -$1.76M | $1.50M |
| Operating Cash Flow | -$15.71M | -$15.90M | -$22.48M | -$21.34M | -$22.71M | -$21.20M | -$25.08M | -$17.03M |
| Capital Expenditure | -- | -- | -- | -$3.0K | -$8.0K | -$98K | -$448K | -$233K |
| Free Cash Flow | -- | -- | -- | -$21.34M | -$22.72M | -$21.30M | -$25.53M | -$17.27M |
| Investing Cash Flow | -- | -- | -- | -$3.0K | -$8.0K | -$98K | -$448K | -$233K |
| Common Stock Issued | -- | -- | $170K | -- | -- | -- | -- | -- |
| Financing Cash Flow | $83K | -$127K | $4.11M | $25.22M | $78.09M | $1.48M | $171K | $67K |
| Net Change in Cash | -$15.62M | -$16.03M | -$18.37M | $3.88M | $55.37M | -$19.82M | -$25.36M | -$17.20M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Gross Margin | -- | 46.2% | 35.8% |
| Operating Margin | -- | -100571.0% | -42363.3% |
| Net Profit Margin | -- | -73864.5% | -64242.5% |
| Return on Equity (ROE) | -1490.3% | -241.7% | -- |
| Return on Assets (ROA) | -116.1% | -63.6% | -101.2% |
| Current Ratio | 4.78x | 3.63x | 3.19x |
| Quick Ratio | 4.45x | 3.63x | 3.18x |
| Debt to Equity | 3.28x | 1.14x | -- |
| Revenue Growth (YoY) | -100.0% | -22.5% | -- |
| Gross Profit Growth (YoY) | -100.0% | 0.0% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -- | -- | -- | -- | -- | -- | -- | 46.2% |
| Operating Margin | -- | -- | -- | -- | -- | -- | -- | -100571.0% |
| Net Profit Margin | -- | -- | -- | -- | -- | -- | -- | -73864.5% |
| Return on Equity (ROE) | -- | -- | -505.2% | -1490.3% | -- | -- | -1397.8% | -241.7% |
| Return on Assets (ROA) | -112.5% | -128.9% | -108.7% | -116.1% | -106.9% | -160.9% | -107.3% | -63.6% |
| Current Ratio | 1.98x | 3.15x | 4.28x | 4.78x | 4.27x | 1.22x | 2.50x | 3.63x |
| Quick Ratio | 1.82x | 3.00x | 4.10x | 4.45x | 4.16x | 1.02x | 2.24x | 3.63x |
| Debt to Equity | -- | -- | 1.44x | 3.28x | -- | -- | 5.03x | 1.14x |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -57.1% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -40.0% |